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Introduction
Radiofrequency ablation is an effective treatment strategy for ischemic and non-ischemic 
cardiomyopathy-related ventricular tachycardia (VT). The role of substrate-guided ablation, 
performed using electrogram characteristics (low amplitude, fractionated or isolated 
potentials) as scar surrogates, is expanding due to frequent hemodynamic instability during 
entrainment mapping of scar-related VT. Late gadolinium-enhancement on cardiac magnetic 
resonance imaging (LGE-MRI) can accurately characterize the trans-mural extent, location, 
and configuration of ventricular scar1. Integration of LGE-MRI into electroanatomical 
mapping (EAM) during VT ablation was shown, in preliminary studies, to be feasible and to 
provide accurate localization of VT substrate and re-entry circuits2–4. However, studies to 
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date examining the impact of MRI-scar integration on procedural outcomes have lacked 
control groups, precluding any comparisons with standard practice. We performed a study 
to: 1) demonstrate the feasibility in clinical practice of integrating MRI-derived scar for 
guidance of VT ablation; 2) report on the peri-procedural performance of LGE-MRI in 
identifying the arrhythmogenic substrate; and 3) examine the impact of MRI-guided ablation 
on procedural length and acute and long-term outcomes.
Study Design
In this prospective multi-center study, we enrolled 24 consecutive patients with ischemic 
(n=9) and/or non-ischemic cardiomyopathy (n=15), referred for catheter ablation of scar-
related monomorphic VT. Patients were assigned, at the discretion of the treating physician 
(not randomized), to undergo either MRI-derived scar guided ablation or traditional ablation. 
Clinical characteristics of patients in both groups were statistically comparable with a higher 
tendency to use scar-integration for patients with prior failed ablation, lower LVEF and 
epicardial circuits (Supplemental Table 1).
MRI acquisition and analysis, as well as standard ablation strategy, are fully described in the 
supplement. Briefly, an EP study, using programmed stimulation, was performed at the 
procedure onset to induce the clinical VT(s), and to enable the identification and ablation of 
VT critical sites by pace- or entrainment-mapping. Additional ablation targets included areas 
with fractionated, isolated and low-voltage potentials. In MRI-scar guided ablation, 
registration of LGE-map and EAM was accomplished, and regions exhibiting LGE were 
carefully interrogated to identify low-voltage or abnormal electrograms. Entrainment or 
pace-mapping maneuvers were then performed in regions with LGE to ascertain their 
involvement in clinical VT. LGE areas were ablated if found to be implicated in VT and 
areas with LGE and abnormal electrograms were ablated in a substrate modification strategy 
if VT could not be induced/mapped. Figure 1 displays examples of VT ablation performed 
with and without MRI-scar integration.
Patients were followed post-procedure with regular ICD interrogations, Holter-monitoring, 
or ECG-recordings. The primary endpoint was long-term freedom from target-VT 
recurrence.
Results
Supplemental Table 1 and Supplemental Figure 2 exhibit procedural and MRI-scar data, 
respectively. In the scar-integration group, all patients with inducible-VTs had evidence of 
LGE on MRI, and ablation within or at the border of LGE sites terminated the arrhythmia in 
all these patients (100% match between clinical VT critical sites and LGE). In patients 
without LGE on MRI, sustained VT could not be induced. In one patient with non-ischemic 
cardiomyopathy, MRI revealed LGE in the mid-inferior wall, correlating with low-voltage 
and abnormal potentials on EAM. In this patient, VT could not be elicited on various 
maneuvers and substrate modification was done using radiofrequency energy in that area. 
Data on interrogation of LGE areas for abnormal electrograms was available in 9/13 patients 
in scar-merge group. Abnormal electrograms were co-localized with LGE in all patients and 
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were targeted by ablation in patients in whom a substrate modification approach was 
adopted. Procedural, fluoroscopy, and ablation times, as well as ablation burden were similar 
in both study arms (p>0.05). Acute procedural success (clinical VT termination and/or non-
inducibility) was achieved in all patients.
During a median follow-up of 38.5 IQR[26–53] months, 16(73%) patients had VT 
recurrence (7 in the study group vs. 9 controls, Supplemental Table 2). After adjusting for 
age, gender, cardiac substrate, epicardial ablation, and LVEF, MRI-guided ablation was 
associated with reduced VT recurrence during follow-up (HR 0.12, 95% CI 0.02–0.75, 
p=0.023). Follow-up echocardiographic studies were performed in a subset of patients and 
described in the Supplement.
Discussion
The current study is the first to evaluate the impact of integration of LGE-MRI scar into 
EAM during VT ablation on long-term procedural outcome using a control group for 
comparison. The main findings of this study are: 1) integration of MRI-derived scar during 
VT-ablation is feasible; 2) MRI-defined scar accurately identifies VT-substrate without 
differences upon procedural or fluoroscopy time; 3) acute ablation success rates were similar 
in procedures performed with and without scar-merging; and 4) after adjusting for clinical 
parameters, MRI-guided ablation was associated with decreased risk of long-term VT 
recurrence.
Incorporation of the LGE-derived scar facilitates VT ablation in the setting of hemodynamic 
instability that precludes conventional electrophysiological mapping and dense point-by-
point voltage mapping, and may shorten procedure time devoted to substrate identification. 
LGE-MRI can also complement VT-substrate mapping by focusing substrate-mapping on 
scar regions. Indeed, regional necrosis/fibrosis is accompanied by hypertrophy of adjacent 
viable tissue (as a result of remodeling)5, exhibit normal voltage and be glossed over after 
identification of sparse neighboring ‘healthy’ points. Mid-wall scar may also contain critical 
parts of VT-reentry circuits and, while missed upon bipolar-voltage mapping, can be 
displayed upon integration of MRI-scar. We believe that scar-integration enhances the 
operator’s ability to target substrate that would otherwise have been missed, potentially 
improving patient outcomes. In addition, MRI-scar integration may impact safety by 
avoiding unnecessary ablation of healthy myocardium in procedures guided solely by 
voltage-mapping. In fact, false-positive low-voltage may be due to poor contact, thinner 
walls, or epicardial fat, leading to over-estimation of arrhythmogenic substrate. Study 
limitations are listed in the supplement.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Panel A displays a representative example of VT ablation performed without MRI-derived 
scar integration. Endocardial EAM identified scar at the basal infero-lateral region of the left 
ventricle, the ablation of which terminated clinical VT. Panel B displays a representative 
example of VT ablation performed with MRI-derived scar integration. Voltage map of the 
RV was constructed and merged with the previously acquired MRI (both segmented 
anatomical shell in blue as well as scar in grey). A basal septal and inferior RV scar noted on 
LGE-MRI (marked by an asterisk) closely matched the areas of low voltage, fractionated 
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and isolated potentials found on EAM. Substrate modification was performed within the 
scar. No sustained VT was inducible subsequently.
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